First Citizens Bank & Trust Co. Purchases New Holdings in BWX Technologies, Inc. $BWXT

First Citizens Bank & Trust Co. bought a new stake in BWX Technologies, Inc. (NYSE:BWXT) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 6,283 shares of the technology company’s stock, valued at approximately $1,285,000.

A number of other institutional investors have also modified their holdings of BWXT. Goldman Sachs Group Inc. grew its position in BWX Technologies by 0.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 141,680 shares of the technology company’s stock valued at $13,977,000 after buying an additional 371 shares during the last quarter. Caxton Associates LLP purchased a new position in BWX Technologies during the 1st quarter worth $304,000. Flow Traders U.S. LLC acquired a new stake in shares of BWX Technologies in the 2nd quarter worth $404,000. NewEdge Advisors LLC lifted its stake in shares of BWX Technologies by 670.0% in the 2nd quarter. NewEdge Advisors LLC now owns 7,030 shares of the technology company’s stock worth $1,013,000 after acquiring an additional 6,117 shares during the period. Finally, Sei Investments Co. boosted its holdings in shares of BWX Technologies by 44.9% in the second quarter. Sei Investments Co. now owns 256,969 shares of the technology company’s stock valued at $37,018,000 after acquiring an additional 79,646 shares in the last quarter. Institutional investors and hedge funds own 94.39% of the company’s stock.

BWX Technologies Stock Up 0.8%

Shares of NYSE BWXT opened at $176.53 on Friday. The company has a quick ratio of 2.33, a current ratio of 2.40 and a debt-to-equity ratio of 1.58. BWX Technologies, Inc. has a 52 week low of $142.72 and a 52 week high of $241.82. The firm has a 50-day moving average price of $192.02 and a 200 day moving average price of $202.94. The stock has a market capitalization of $16.17 billion, a price-to-earnings ratio of 47.20, a price-to-earnings-growth ratio of 2.99 and a beta of 0.74.

BWX Technologies (NYSE:BWXT) last issued its earnings results on Monday, May 4th. The technology company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $0.92 by $0.20. BWX Technologies had a net margin of 10.20% and a return on equity of 31.33%. The company had revenue of $860.22 million for the quarter, compared to analyst estimates of $837.47 million. During the same period in the prior year, the business posted $0.91 earnings per share. The firm’s revenue for the quarter was up 26.1% compared to the same quarter last year. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. Equities research analysts anticipate that BWX Technologies, Inc. will post 4.6 EPS for the current fiscal year.

BWX Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, June 5th. Shareholders of record on Tuesday, May 19th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date was Tuesday, May 19th. BWX Technologies’s payout ratio is presently 28.88%.

Insiders Place Their Bets

In other BWX Technologies news, CFO Michael Thomas Fitzgerald sold 2,417 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $209.25, for a total value of $505,757.25. Following the sale, the chief financial officer owned 6,884 shares of the company’s stock, valued at approximately $1,440,477. This represents a 25.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Rex D. Geveden sold 10,000 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $204.81, for a total value of $2,048,100.00. Following the completion of the transaction, the chief executive officer owned 202,491 shares of the company’s stock, valued at approximately $41,472,181.71. This represents a 4.71% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on BWXT shares. Seaport Research Partners upgraded shares of BWX Technologies from a “neutral” rating to a “buy” rating and set a $245.00 price target on the stock in a research note on Monday, June 22nd. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of BWX Technologies in a report on Friday, May 22nd. Truist Financial boosted their target price on BWX Technologies from $205.00 to $212.00 and gave the stock a “hold” rating in a research report on Monday, May 11th. Wells Fargo & Company started coverage on BWX Technologies in a research note on Wednesday, April 1st. They set an “underweight” rating and a $200.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft raised BWX Technologies from a “hold” rating to a “buy” rating and raised their price target for the company from $205.00 to $255.00 in a report on Friday, May 15th. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $228.00.

BWX Technologies Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.